IP Library Granted Patent US 8,697,175
Granted Patent B2
US 8,697,175 · App. 13/412,407 · Granted Apr 15, 2014

Endoluminal device for in vivo delivery of bioactive agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,697,175
App. No.
13/412,407
Granted
Apr 15, 2014
Kind
B2
Abstract

The present invention consists of an implantable structural element for in vivo delivery of bioactive active agents to a situs in a body. The implantable structural element may be configured as an implantable prosthesis, such as an endoluminal stent, cardiac valve, osteal implant or the like, which serves a dual function of being prosthetic and a carrier for a bioactive agent. Alternatively, the implantable structural element may simply be an implantable article that serves the single function of acting as a time-release carrier for the bioactive agent.

Claims (25)

1. A method of forming a stent structure, comprising the steps of:

a. forming a region of an internal cavity of a strut with a sacrificial material;

b. depositing a layer of structural material over the sacrificial material;

c. forming one or more holes in the structural material providing fluid communication between the sacrificial material and the area external the structural material; and

d. removing the sacrificial material forming the region of the internal cavity.

2. The method of claim 1 , wherein the step of removing the sacrificial material forming the region of the internal cavity is performed by etching.

3. The method of claim 1 , further comprising the step of forming regions of one or more holes with sacrificial material, wherein the step of forming one or more holes in the structural material comprises removing the sacrificial material forming the regions of one or more holes by etching.

4. The method of claim 3 , wherein the step of depositing a layer of structural material over the sacrificial material does not include depositing structural material over the sacrificial material forming regions of one or more holes.

5. The method of claim 1 , wherein the step of forming one or more holes in the structural material comprises one of the methods of formation selected from the group consisting of microdrilling, laser cutting, etching, and EDM.

6. The method of claim 1 , wherein the step of depositing a layer of structural material comprises using a vacuum deposition technique selected from the group consisting of sputtering, reactive ion etching, chemical vapor deposition, and plasma vapor deposition.

7. The method of claim 1 , further comprising the step of depositing a bioactive agent within the internal cavity.

8. The method of claim 1 , wherein the resulting stent structure is generally tubular in shape.

9. A method of forming a stent structure, comprising the steps of:

a. providing a base layer of structural material;

b. depositing sacrificial material onto the base layer, forming a region of an internal cavity of a strut;

c. depositing a layer of structural material over the sacrificial material;

d. forming one or more holes in the structural material providing fluid communication between the sacrificial material and the area external the structural material; and

e. removing the sacrificial material forming the region of the internal cavity.

10. The method of claim 9 , wherein the resulting stent is generally tubular in shape.

11. The method of claim 9 , further comprising the step of forming regions of one or more holes with sacrificial material, wherein the step of forming one or more holes in the structural material comprises removing the sacrificial material forming the regions of one or more holes by etching.

12. The method of claim 11 , wherein the step of depositing a layer of structural material over the sacrificial material does not include depositing structural material over the sacrificial material forming regions of one or more holes.

13. The method of claim 9 , wherein the step of forming one or more holes in the structural material comprises one of the methods of formation selected from the group consisting of microdrilling, laser cutting, etching, and EDM.

14. The method of claim 9 , wherein the step of depositing a layer of structural material comprises using a vacuum deposition technique selected from the group consisting of sputtering, reactive ion etching, chemical vapor deposition, and plasma vapor deposition.

15. The method of claim 9 , further comprising the step of depositing a bioactive agent within the internal cavity.

16. The method of claim 9 , wherein the step of removing the sacrificial material forming the region of the internal cavity is performed by etching.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2018
From: VACTRONIX SCIENTIFIC, INC.
To: VACTRONIX SCIENTIFIC, LLC
Reel/Frame 046196/0616 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2017
From: ADVANCED BIO PROSTHETIC SURFACES, LTD., A WHOLLY OWNED SUBSIDIARY OF PALMAZ SCIENTIFIC, INC.
To: VACTRONIX SCIENTIFIC, INC.
Reel/Frame 042124/0001 →
SECURITY INTEREST Recorded Feb 17, 2016
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: OAK COURT PARTNERS, LTD.
Reel/Frame 037839/0278 →
SECURITY INTEREST Recorded Feb 16, 2016
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: OAK COURT PARTNERS, LTD.
Reel/Frame 037836/0646 →
SECURITY INTEREST Recorded Feb 16, 2016
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: OAK COURT PARTNERS, LTD.
Reel/Frame 037827/0568 →
SECURITY INTEREST Recorded Feb 15, 2016
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: PALMAZ, JULIO
Reel/Frame 037820/0400 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF ASSIGNEE PREVIOUSLY RECORDED AT REEL: 036384 FRAME: 0818. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Aug 24, 2015
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: LENNOX CAPITAL PARTNERS, LP
Reel/Frame 036465/0091 →
SECURITY INTEREST Recorded Aug 24, 2015
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: SPI DALLAS INVESTMENTS, LP
Reel/Frame 036434/0813 →
SECURITY INTEREST Recorded Aug 18, 2015
From: PALMAZ SCIENTIFIC INC.; ADVANCED BIO PROSTHETIC SURFACES, LTD.; ABPS VENTURE ONE, LTD.
To: SPI DALLAS INVESTMENTS, LP
Reel/Frame 036384/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2013
From: BOYLE, CHRISTOPHER T.
To: ADVANCED BIO PROSTHETIC SURFACES, LTD., A WHOLLY OWNED SUBSIDIARY OF PALMAZ SCIENTIFIC, INC.
Reel/Frame 030279/0475 →